title: Risperidone versus placebo for schizophrenia.
authors.affiliation: North Yorkshire and York NHS Trust, York, UK. rdrattehalli@hotmail.com
authors.forename: Ranganath D
authors.initials: RD
authors.lastname: Rattehalli
authors.forename: Mahesh B
authors.initials: MB
authors.lastname: Jayaram
authors.forename: Michael
authors.initials: M
authors.lastname: Smith
mesh_terms: D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010054:Brief Psychiatric Rating Scale; D006801:Humans; D008609:Mental Status Schedule; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D016032:Randomized Controlled Trials as Topic; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone